【摘要】 :[目的]分析心肌梗死(MI)患者住院治疗状况。[方法]2004年1月至2008年5月心肌梗死患者,对治疗状况进行调查分析。[结果]50.9%的AMI患者行急诊PCI,阿司匹林、氯吡格雷、低分子肝素、ACEI/ARB、他汀类药物、中药的使用情况较好,β受体阻滞剂的使用率偏低。[结论]MI治疗基本上遵循了国际上公认的指南,但β受体阻滞剂使用仍有提升的空间,中药得到了广泛的应用,但其疗效缺乏大量的循证医学证据。
【关键词】 心肌梗死; 再灌注; 治疗状况
Abstract:[Objective] To analyse the therapies of the hospitalized patients with myocardial infarction(MI). [Methods] To select the hospitalized patients with myocardial infarction between January 2004 and May 2008 and to investigate the patients, therapies. [Results] 50.9% of the AMI patients received therapy of emergency PCI and the utilization rates of aspirin, clopidogrel, lowmolecularweight heparin, ACEI/ ARB, statins; Chinese medicine was better but the utilization rate of betablocker was slightly lower. [Conclusions]The guidelines were implemented in the therapies of myocardial infarction patients, but the use of betablocker still could be improved, Chinese medicine was widely used, but still needed to be proved by evidencebased medicine.
Key words: myocardial infarction; reperfusion; current status of therapies
心肌梗死( myocardial infarction, MI)是在冠脉严重病变的基础上,由于血管内斑块的糜烂和破裂并发血栓形成,血管痉挛等因素使冠脉血供急剧减少或中断所致的急性心肌缺血坏死,是冠心病严重类型,也是心血管病的重要致死原因之一,属中医的“胸痹心痛”、“真心痛”、“厥心痛”等范畴。本文旨在调查统计分析在我院住院治疗的心肌梗死患者的治疗状况,了解对指南的遵循情况。
1 调查对象及方法
1.1 调查对象
参照2007年ESC/ACCF/AHA/WHF(European Society of Cardiology/ American College of Cardiology Foundation/ American Heart Association/ World Heart Federation)急性心肌梗死(acute myocardial infarction, AMI)和陈旧性心肌梗死(old myocardial infarction, OMI)的诊断标准[1]入选2004年1月至2008年5月在我院心内科住院治疗的患者170例,男124例,女46例,年龄29~86岁,平均(69.72±13.24)岁,其中AMI的患者106例(ST段抬高的心肌梗死(STelevation myocardiol infarction, STEMI)患者101例,非ST段抬高的心肌梗死(nonSTelevation myocardiol infarction, NSTEMI)患者5例;男/女:67/39),OMI的患者64例(男/女:57/7)。排除标准:24h内出院或死亡的病例。
1.2 调查方法 [1] [2] [3] 下一页 |